BANK VONTOBEL/PUT/ELI LILLY & CO/720/0.1/20.09.24 Share Price

Warrant

DE000VM92QP7

Delayed Deutsche Boerse AG 09:11:37 01/07/2024 BST
0.37 EUR 0.00% Intraday chart for BANK VONTOBEL/PUT/ELI LILLY & CO/720/0.1/20.09.24
Current month-77.16%
1 month-79.56%
Date Price Change
01/07/24 0.37 0.00%
28/06/24 0.37 -11.90%
27/06/24 0.42 -8.70%
26/06/24 0.46 +6.98%
25/06/24 0.43 -6.52%

Delayed Quote Deutsche Boerse AG

Last update July 01, 2024 at 09:11 am

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying ELI LILLY AND COMPANY
IssuerLogo Issuer Vontobel Vontobel
WKN VM92QP
ISINDE000VM92QP7
Date issued 08/02/2024
Strike 720 $
Maturity 20/09/2024 (82 Days)
Parity 10 : 1
Emission price 4.98
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 5.44
Lowest since issue 0.36
Delta-0.06x
Omega 13.39
Premium20.93x
Gearing221.68x
Moneyness 0.7952
Difference Strike -185.4 $
Difference Strike %-25.75%
Spread 0.02
Spread %5.13%
Intrinsic value 0.000000

Company Profile

Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.5%); - immunology diseases (11.1%); - neurology (8.4%): primarily drugs used in treating depression and schizophrenia; - other (3.3%). Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
More about the company

Ratings for Eli Lilly and Company

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Eli Lilly and Company

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
905.4 USD
Average target price
868.9 USD
Spread / Average Target
-4.03%
Consensus